Cardiovascular Systems to Webcast Fiscal 2014 Fourth-Quarter Earnings Conference Call Wednesday, August 6
July 23 2014 - 4:39PM
Business Wire
Live Webcast at 3:45 p.m. CT (4:45 p.m.
ET)
Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a
live webcast of its fiscal 2014 fourth-quarter conference call on
Wednesday, August 6, 2014, at 3:45 p.m. CT (4:45 p.m. ET). David
Martin, President and Chief Executive Officer, and Larry Betterley,
Chief Financial Officer, will discuss the company’s results for its
fiscal fourth quarter ended June 30, 2014, and its financial
outlook. The company will issue a post-market earnings release
prior to the call on August 6.
To access the live webcast, go to the investor section of the
company’s website, www.csi360.com, on the day of the conference
call and click on the webcast icon. A webcast replay will be
available beginning at 7:45 p.m. CT the same day.
To participate in the conference call, dial (888) 679-8034 and
enter 56131688. Please dial in at least 10 minutes prior to the
call. To pre-register for the call, log on to the following
website:
https://www.theconferencingservice.com/prereg/key.process?key=PBYLBG7H4.
When joining the call, pre-registered participants can enter their
PIN code, and other participants can press *0 to reach the
operator, or wait on the line for operator assistance.
If you do not have access to the Internet and want to listen to
an audio replay of the conference call, dial (888) 286-8010 and
enter access number 33941614. The audio replay will be available
beginning at 7:45 p.m. CT on Wednesday, August 6, 2014, through
10:59 p.m. CT on Wednesday, August 13, 2014.
About Cardiovascular Systems, Inc.Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device company focused
on developing and commercializing innovative solutions for treating
vascular and coronary disease. The company’s Orbital Atherectomy
Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg and heart in a few minutes of treatment time,
and address many of the limitations associated with existing
surgical, catheter and pharmacological treatment alternatives. The
U.S. FDA granted 510(k) clearance for the use of the Diamondback
Orbital Atherectomy System in August 2007. To date, over 146,000 of
CSI’s devices have been sold to leading institutions across the
United States. In October 2013, the company received FDA approval
for the use of the Diamondback Orbital Atherectomy System in
coronary arteries. For more information, visit the company’s
website at www.csi360.com.
Cardiovascular Systems, Inc.Jack Nielsen,
651-202-4919j.nielsen@csi360.comorPadillaCRTMatt Sullivan,
612-455-1709matt.sullivan@padillacrt.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From May 2024 to Jun 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2023 to Jun 2024